Search results
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 5 days agoLilly, with a market cap of more than $800 billion, boasts a diversified product profile, including...
Warm and Fuzzy: Savannah restaurants serve up Peach Week to help CURE Childhood Cancer
Gannett via AOL· 11 hours agoFor the second year, Pearson Farms has teamed up with the nonprofit CURE Childhood Cancer and 10...
Does 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead?
Insider Monkey via Yahoo Finance· 1 day agoBrown Capital Management, an investment management company, released its “The Brown Capital...
FDA: Switching Studies Are Not Needed for Interchangeability
Medscape· 17 hours agoThe US Food and Drug Administration (FDA) has issued new draft guidance that does not require...
If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 2 days agoAbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica. Its newest immunology...
Sonelokimab Yields Significant Improvements in Active PsA
Medscape· 17 hours agoPatients receiving sonelokimab experienced higher treatment response in ACR20, ACR50, and PASI90...
Here's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 5 days agoIts pharmaceutical product categories are neuroscience (Cymbalta, Emgality and others), diabetes...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 4 days agoAnd AstraZeneca has some ambitious growth targets ahead. By 2030, management believes it can generate $80 billion in annual revenue. It expects to grow...
La Jolla News Nuggets: Baby seadragons, Pier to Cove Swim, science honors, more
U-T San Diego· 1 day agoMore than 70 weedy seadragons were hatched this month at the Birch Aquarium at UC San Diego’s...
CHICAGO TRUST Co NA Has $6.20 Million Position in Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 1 day agoCHICAGO TRUST Co NA raised its stake in Merck & Co., Inc. (NYSE:MRK – Free Report) by 3.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission ...